Grants

New Gilead – Giving in Africa

Our grantmaking in Africa focuses on the following therapeutic areas are HIV/AIDS and Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including:

• Disease awareness
• Disease prevention
• Professional education
• Improving patient access to care
• Improving quality of care
• Increasing scientific capacity
• Strengthening healthcare systems

Due date: Grant applications are accepted year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review.

For more information click; https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-africa

 Seeding Labs Apply for Equipment

At Seeding Labs, we equip scientists everywhere to lead the way to brighter and healthier futures Through Instrumental Access, Seeding Labs connects universities and research institutes in low- and middle-income countries with high-quality laboratory equipment.

Due date: You can submit your application at any time, but these are the upcoming dates when applications will be reviewed: 14 August 2026 or 16 October 2026

For more information click; https://seedinglabs.org/instrumental-access-application/

 

Call for Proposals: Development Innovation Ventures (DIV) Fund

We accept proposals from all organization types operating in any sector or geography within low- and middle-income countries, across a wide range of solution types and paths to scale, including both commercial and public-sector adoption. We offer three award tiers – Stage 1 (Piloting), Stage 2 (Testing), and Stage 3 (Scaling) – with requirements calibrated according to the strength of the evidence of impact, cost-effectiveness, and the potential for durable scale of the proposed innovation. Applicants should apply for the stage that best reflects the current state of development of the innovation and its readiness to generate stronger evidence and prepare for scale. While you do not need to start at Stage 1, if applying for later stage awards, your application should credibly demonstrate that you have already met the criteria for earlier stages.

Due date: Applications are accepted on a rolling basis.

For more information click; https://www.div.fund/apply#how-to-apply

 

New Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Current recipients of specific types of NIH research grants may apply for administrative supplements, using this Notice of Funding Opportunity (NOFO), to provide additional funding to a currently funded grant to meet increased costs that are within the scope of the peer-reviewed and approved project, but that were unforeseen when the new or competing renewal application was awarded. Applications for administrative supplements are considered prior approval requests (as described in Section 8.1.2.11 of the NIH Grants Policy Statement) and will be routed directly to the Grants Management Officer of the parent award. There is no guarantee that funds are available from the awarding IC or for any specific grant. Therefore, prior to submission, applicants must discuss potential requests with the awarding ICO grants and program officials. 

For more information click; https://files.simpler.grants.gov/opportunities/bd113473-bd20-4739-95e0-51131671558a/attachments/fad88583-05c7-4b0b-a1b1-8a289438e3ce/PA-26-001-Full-Announcement.html

 

Michelson Prizes: Next Generation Grants

Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases. The committee will look for research that aims to tackle the current roadblocks to human vaccine development and expand our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. While the Michelson Prizes are focused on research in the fields of immunology, vaccine, and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply.

Due date: June 22, 2026, 11:59 pm EDT (UTC-4)

For more information click; https://www.michelsonmedicalresearch.org/michelson-prizes-next-generation

 

New Quarterly Research Grant Funding Programme

This programme funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief. For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible, so please contact us ahead of submission if you are thinking of applying for a clinical trial.

Due date: June 22, 2026, 23:59pm BST

For more information click; https://cureparkinsons.org.uk/research/for-researchers/apply-for-funding/quarterly-research-grant/

 

NIHR Global Health Research Professorships (Cohort 9)

The Global Health Research Professorships award is a professorial-level funding opportunity. You can apply if you are an outstanding academic who is on track to become a future Global Health research leader. The award promotes effective translation of research. This award will fund up to £2,000,000 over 5 years to undertake a research project, cover salary costs, training and development, and institutional capacity strengthening in LMICs. Your proposed research project must be within our Global Health Research remit for career development awards. Your application must focus on addressing global health security threats and challenges, improving the ability of health systems to protect the health of the poorest and most vulnerable in sub-Saharan Africa and South Asia. This, includes maternal, newborn, child, and adolescent health.

Due date: 30 June 2026 at 1:00 pm.

For more information, click: https://www.nihr.ac.uk/funding/global-health-research-professorships-cohort-9/2026423

 

Request for Proposals: Clinical Cancer Research Grant Program

The Clinical Cancer Research Grant Program supports patient-focused interventional clinical trials in cancer research. The goal is to advance clinical studies that can directly improve outcomes for patients by:

• Optimizing cancer therapies

• Reducing disease and treatment burden

• Supporting earlier detection and intervention

• Improving quality of life during and after treatment

The programme is specifically intended for interventional clinical trials and does not support basic or purely observational research.

Due date: June 22, 2026, 23:59 CET

For more information click; https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

 

NIHR Tackling bacterial and fungal antimicrobial resistance in sub-Saharan Africa and South Asia

Our 2026 Global Health Research theme is antimicrobial resistance (AMR), with a focus on bacterial and fungal pathogens on the World Health Organisation (WHO) priority lists. This choice of theme was informed by existing areas of need, including those identified by the WHO Global Research Agenda for AMR, horizon scanning and a consultation with key stakeholders. It was further refined by experts from an independent scientific advisory group.

This process highlighted a lack of evidence on real-world implementation of interventions designed to:

• strengthen antimicrobial stewardship
• prevent AMR infections
• improve AMR-related health outcomes

This is a 2-stage, researcher-led funding opportunity. To apply for the first stage, you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

Due date: 8 July 2026 at 1:00 pm

For more information click; https://www.nihr.ac.uk/funding/tackling-bacterial-and-fungal-antimicrobial-resistance-sub-saharan-africa-and-south-asia/2026402

 

New Spencer Foundation – Research-Practice Partnerships: Collaborative Research for Educational Change

The Research-Practice Partnership (RPP) Grants Program is intended to support education research projects that engage in collaborative and participatory partnerships with project budgets up to $400,000 and durations of up to three years. We accept preproposals once a year in this program. We view partnerships as an important approach to knowledge generation and the improvement of education, broadly construed. Over the long term, we anticipate that research conducted by RPPs will result in new insights into the processes, practices, and policies that improve education for learners, educators, families, communities, and institutions where learning and teaching happen (e.g., schools, universities, community centers, parks, museums, other workplaces).

Due date for Pre-proposal: July 10, 2026, 12:00 PM Noon (Central/Chicago Time)

For more information click; https://www.spencer.org/grant_types/research-practice-partnerships

 

E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive. For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Due date for Concept: 14 July 2026 (Noon Mountain Time)

For more information click; https://www.thrasherresearch.org/al-thrasher-award?lang=eng

 

Mental Health Award: Using physical activity and circadian-based interventions to reduce anxiety and depression in young people

This award will fund mechanistically informed trials of interventions for anxiety and depression in young people aged 10-18 years. Successful teams will build on existing mechanistic evidence to develop more precise and effective early interventions that have the potential to scale.

Due date: 14 July 2026, 15:00 BST)

For more information click; https://wellcome.org/research-funding/schemes/mental-health-award-using-physical-activity-and-circadian-based-0

 

John Templeton Foundation Grants for Interdisciplinary Research

The John Templeton Foundation supports interdisciplinary research and public engagement that inspire awe, wonder, and curiosity about the universe. Its funding encourages intellectual exploration while promoting lives of meaning, purpose, and ethical reflection. The Foundation’s grants span multiple areas:

• Character Virtue Development – Research and initiatives that promote moral and personal growth.

• Individual Freedom & Free Markets – Studies and programs that examine liberty, economic freedom, and societal impact.

• Life Sciences – Advancing understanding of biology, health, and human development.

• Mathematical & Physical Sciences – Support for fundamental research in physics, mathematics, and related fields.

• Public Engagement – Initiatives that make research accessible and meaningful to wider audiences.

• Religion, Science, and Society – Projects exploring the interaction between faith, scientific inquiry, and societal development.

Due date for Concept: 14 July 2026 (Noon Mountain Time)

For more information click; https://www.templeton.org/grants/grant-calendar

 

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Due date: 21 July 2026, 15:00 BST

For more information click; https://wellcome.org/research-funding/schemes/wellcome-early-career-awards

 

Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 28 July 2026, 15:00 BST

For more information click; https://wellcome.org/research-funding/schemes/wellcome-career-development-awards

 

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from low- and middle-income country (LMIC) and U.S. institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). FIC will support research training programs that focus on 1) major endemic or life-threatening emerging infectious diseases, 2) neglected tropical diseases, 3) infections that frequently occur as co-infections in HIV infected individuals or 4) infections or microbiomes associated with non-communicable disease conditions of public health importance in LMICs. Advanced scientific training related to prevention, treatment or public health approaches to any technical area of basic, epidemiological, clinical, behavioral or social science health research may be supported. Research training programs should incorporate didactic, mentored research and professional development skills components to prepare individuals for sustainable careers that will have significant impact on the priority health research needs of LMICs.

Due date: 6 August 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html

 

New The Spencer Foundation Vision Grant program

The Spencer Foundation invests in research to improve education, broadly conceived. We know that rigorous research can play a critical role in identifying systemic inequities, evaluating what actually works, and guiding evidence-based changes that make education systems fairer and more inclusive.  The Vision Grant program provides scholars and collaborators with the time, space, resources, and support to plan a large-scale study or program of research: geared toward real-world impact to make education systems more equitable; drawing on research across disciplines and methods; and developed through meaningful and equitable collaboration with practitioners, policymakers, communities, and other partners; and focused on transforming educational systems.   

Due date for Intent: August 12, 2026, 12:00 PM Noon (Central/Chicago Time)

For more information click: https://www.spencer.org/grant_types/vision-grants

 

New Upcoming funding opportunity – Addressing Neglected Areas of Sexual and Reproductive Health and Rights in sub-Saharan Africa

The Addressing Neglected Areas of Sexual and Reproductive Health and Rights in sub-Saharan Africa (ANeSA) initiative is issuing a preannouncement of an upcoming two-stage funding opportunity. The call of Letters of Interest is expected to launch on June 29, 2026. The initiative will support up to six additional Implementation Research Teams, with grants of up to CAD 1.2 million each. Up to 12 teams will be invited to submit full proposals in the second stage. ANeSA aims to support greater realization of neglected sexual and reproductive health and rights by under-served populations, including women and girls, men and boys, and gender diverse people, in sub-Saharan Africa. ANeSA five priority areas are: 

• Improving access to family planning and contraceptive services
• Expanding access to safe abortion care, where legally permitted, and post-abortion care (APAC)
• Upholding SRHR rights and ensuring access to services for adolescents
• Preventing sexual- and gender-based violence (SGBV) and improving services for people experiencing SGBV
• Strengthening advocacy for SRHR

Due date for letters of interest: August 23, 2026 – 00:00 ET

For more information click: https://idrc-crdi.ca/en/funding/upcoming-funding-opportunity-addressing-neglected-areas-sexual-and-reproductive-health-and?utm_source=Funding+Alerts&utm_campaign=8f90ee9da2-EMAIL_CAMPAIGN_7_31_2020_9_57_COPY_01&utm_medium=email&utm_term=0_02f2dae0ce-8f90ee9da2-480695917

 

New Global Public Health Awards for Early Career Investigators

The Global Public Health Awards support early career investigators from low- and middle-income countries working on HIV and viral hepatitis (B, C, and D). The programme funds independent research that strengthens country-driven public health priorities, particularly in prevention, implementation science, and disease management. Focus Areas

• HIV prevention, treatment, and management research

• Viral hepatitis (B, C, D) research and control strategies

• Implementation science and health systems research

• Public health innovation aligned with Sustainable Development Goals (SDGs)

• Cross-disciplinary research (economics, psychology, anthropology, engineering)

Due date: 28 Aug 2026, 11:59 PM CEST.

For more information, click: https://researchscholars.gilead.com/public_health/program-specifics/eligibility

 

Merck Stimulating Innovative Research Grant Program 2026

Since 2018, we have been offering research grants to encourage innovation in key areas that will shape the future. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2026, grants are available in the areas further specified below.

• In-vitro models and assays to identify novel therapies for neuroinflammatory diseases – one grant of up to 250,000 EUR per year for up to 2 years.
• Artificial intelligence in cell culture media and process development – one grant of up to 150,000 EUR per year for up to 3 years.
• Innovative approaches to economical remediation of contaminated high volume materials – one grant of up to 150,000 EUR per year for up to 2 years.
• Condensate-based high-sensitivity cell-free screening assays for the modulation of protein-protein interactions  – one grant of up to 100,000 EUR per year for up to 3 years.
• Advancing molecule synthesis and discovery – up to 3 grants each comprising a 1-year full Synthia® Retrosynthesis Software license, training, and extensive interaction with our scientists.

Due date: 31 August 2026

For more information click: https://www.merckgroup.com/en/research/open-innovation/research-grants.html

 

New Neurotorium Clinical Education Grants within Psychiatry and Neurology

Neurotorium Clinical Education Grants support non-profit educational projects for healthcare professionals in psychiatry and neurology. Neurotorium is an educational platform providing free and unbiased material for clinicians, educators, researchers, and all who are interested in learning about the brain. All our educational material is developed, reviewed, and regularly updated by leading experts. You can find more information about Neurotorium here. Neurotorium is offering Clinical Education Grants to support non-profit educational projects aimed at strengthening clinical competencies within the prevention, diagnosis, and treatment of psychiatric and neurological disorders through educational activities aimed at healthcare professionals.

We encourage applications from a diverse pool of applicants and especially encourage projects from, or serving, low-income countries.

Due date: 2 September 2026.

For more information click: https://neurotorium.org/grants/clinical-education-grant/

 

New Global Health EDCTP3 Calls for proposals

Global Health EDCTP3 invests in global health through funding collaborative research and innovation projects tackling infectious diseases and supporting activities for research capacity building in Africa.

• HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02 Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence
• HORIZON-JU-GH-EDCTP3-2026-03-SERP-01 Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms

Due date: 02 September 2026 17:00:00 Brussels time

For more information click: https://www.global-health-edctp3.europa.eu/funding/calls-proposals_en?f%5B0%5D=project_status_project_status%3A41#oe-list-page-filters-anchor

 

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing. 

Due date: 22 September 2026, 15:00 BST

For more information click: https://wellcome.org/research-funding/schemes/wellcome-discovery-awards

 

New Velux Stiftung Ophthalmology Institutional Research Capacity Strengthening Grant Program

The Velux Stiftung has launched the Ophthalmology Institutional Research Capacity Strengthening Grant Program to support long-term biomedical and clinical ophthalmology research development in low- and middle-income countries (LMICs). The program focuses on strengthening institutional research systems, leadership, infrastructure, and sustainable ophthalmology research ecosystems. The initiative supports collaborative projects that help LMIC institutions build lasting research capacity, develop centres of excellence, and improve institutional structures for ophthalmology research and innovation.

Due date: 01 October 2026, 23:59 CEST

For more information click: https://veluxstiftung.ch/funding-areas/ophthalmology/

 

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

The purpose of this engineering-oriented notice of funding opportunity (NOFO) announcement is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. Applications that propose phase III clinical trials are not sought by and will not be supported through this NOFO.

Due date: October 16, 2026

For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html

 

New Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.

Due date: October 16, 2026

For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html

 

New Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.

Due date: October 16, 2026

For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html

 

New The Biocodex Microbiota Foundation Gut Microbiota International Call for Projects

The Biocodex Microbiota Foundation funds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years. The project should involve Microbiome analysis, Immunophenotyping and a dietary component. The project should be primarily performed in humans and in a disease context (Studies purely on healthy subjects are excluded). Pure observational studies should be avoided and some experimental validation is expected.

Due date: 30 November, 2026

For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects

 

New Emerging Global Leader Award (K43 Independent Clinical Trial Required)

The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank  (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

Due date: 3 December 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html

 

New Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank  (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO)invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

Due date: 3 December 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-296.html

 

Fellowships and Scholarships

 

New Call for Applications: Humphrey Fellowship Program 2027/28

The Hubert H. Humphrey Fellowship Program is a one-year, fully funded, professional development program offered to mid-career professionals. Typically, Humphrey Fellows have a record of leadership, a commitment to public service and the initiative to take full advantage of a self-defined program of independent study at a leading American university. The Humphrey Fellowship, a Fulbright exchange, advances American interests by bringing influential professionals from priority countries to the United States to build strategic partnerships that advance shared interests and support U.S. foreign policy goals.  Through graduate-level study and professional experiences at U.S. host universities and organizations, Humphrey Fellows gain practical insight into how American policies are developed and implemented, working alongside U.S. experts in their fields.

Due date: 10 July, 2026

For more information click: https://zw.usembassy.gov/call-for-applications-humphrey-fellowship-program-2027-28/

 

Cancer Prevention Fellowship Program

Established in 1987, the NCI Cancer Prevention Fellowship Program (CPFP) supports postdoctoral fellows from diverse fields for up to four years of mentored research and career development, including a Master of Public Health (MPH) degree for those without prior public health training. The program accepts U.S. citizens, permanent residents, and eligible international applicants from low- and middle-income countries (LMICs).

Due date: August 6, 2026

For more information click: https://trainatnci.cancer.gov/programs/cpfp/

 

New GloCal Health Fellowship

The GloCal Health Fellowship provides aspiring global health researchers with outstanding interdisciplinary education and training in innovative research designed to improve health for populations around the world. A career development fellowship sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC), this program supports awarded fellows from all 10 UC campuses as well as 29 affiliated international sites across 22 countries. UCGHI manages and supports the GloCal Health Fellowship. Ideal candidates will propose research in areas such as, but not limited to:

• HIV
• Infectious Diseases
• Noncommunicable Diseases
• Global Surgery
• Cancer
• Mental Health and Addiction
• Sexual and Reproductive Health
• Planetary Health

Due date: September 15, 2026, 3:00 pm PST

For more information click: https://ucghi.universityofcalifornia.edu/fellowships/glocal-health-fellowship/application-process/

 

Notices

NIH Common Forms Requirements

NIH has adopted the Common Forms as per the White House Office of Science and Technology Policy (OSTP) memorandum on Policy Regarding Use of Common Disclosure Forms. NIH implemented the Biographical Sketch Common Form and the Current and Pending (Other) Support Common Form for Research Performance Progress Reports (RPRRs) and application submissions on or after January 25, 2026. Use of the Common Forms and NIH Biographical Sketch Supplement will be required for all application due dates and Just-In-Time (JIT), Research Performance Progress Report (RPPR), and Prior Approval submissions on or after May 8, 2026. On that date, system warnings will change to errors that will stop any submission not using compliant Common Forms.

For more information on the Announcement, click; https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-079.html

 

New Reminder – Definition of Foreign Components

NIH has recently received questions regarding whether there has been a change in the definition of a foreign component, and whether a foreign co-author on a publication that cites an NIH grant award automatically results in a foreign component.  This notice reminds the extramural community of NIH’s longstanding definition of foreign components.

For more information, click; https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-084.html

 

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from low- and middle-income country (LMIC) and U.S. institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). FIC will support research training programs that focus on 1) major endemic or life-threatening emerging infectious diseases, 2) neglected tropical diseases, 3) infections that frequently occur as co-infections in HIV infected individuals or 4) infections or microbiomes associated with non-communicable disease conditions of public health importance in LMICs. Advanced scientific training related to prevention, treatment or public health approaches to any technical area of basic, epidemiological, clinical, behavioral or social science health research may be supported. Research training programs should incorporate didactic, mentored research and professional development skills components to prepare individuals for sustainable careers that will have significant impact on the priority health research needs of LMICs.

Due date: 6 August 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html

New Merck Stimulating Innovative Research Grant Program 2026

Since 2018, we have been offering research grants to encourage innovation in key areas that will shape the future. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2026, grants are available in the areas further specified below.

• In-vitro models and assays to identify novel therapies for neuroinflammatory diseases – one grant of up to 250,000 EUR per year for up to 2 years.
• Artificial intelligence in cell culture media and process development – one grant of up to 150,000 EUR per year for up to 3 years.
• Innovative approaches to economical remediation of contaminated high volume materials – one grant of up to 150,000 EUR per year for up to 2 years.
• Condensate-based high-sensitivity cell-free screening assays for the modulation of protein-protein interactions  – one grant of up to 100,000 EUR per year for up to 3 years.
• Advancing molecule synthesis and discovery – up to 3 grants each comprising a 1-year full Synthia® Retrosynthesis Software license, training, and extensive interaction with our scientists.

Due date: 31 August 2026

For more information click: https://www.merckgroup.com/en/research/open-innovation/research-grants.html

 

For Expired funding opportunities:

  Click here